View CNVs/SVs
View by Evidence Type: Significant Enriched CNVs (
CNVs Only Present In Patients
de novo CNVs
Overlapping/Recurrent CNVs
CNVs Overlapping With ACRD
CNVs Not Present In Control
Significant Enriched CNVs
Others
All
)
View by Chromosome:All ( 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 X Y All )
Notes: ACRD: Autism Chromosome Rearrangement Database
| CNV Name | Chr | Band | Gain/Loss | Number of CNVs | Evidence Type | Reference | |
|---|---|---|---|---|---|---|---|
| Case | Control | ||||||
| AutCNV0000371 | 16 | 16q23.2 | - | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; | Zwaag, 2009 |
| AutCNV0000372 | 16 | 16q23.2 | - | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; | Zwaag, 2009 |
| AutCNV0000373 | 17 | 17p13.3 | - | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; | Zwaag, 2009 |
| AutCNV0000374 | 17 | 17p11.2 | - | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; | Zwaag, 2009 |
| AutCNV0000375 | 19 | 19p12 | - | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; | Zwaag, 2009 |
| AutCNV0000376 | 19 | 19q13.2 | - | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; | Zwaag, 2009 |
| AutCNV0000377 | 19 | 19q13.2 | - | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; | Zwaag, 2009 |
| AutCNV0000378 | 19 | 19q13.2 | - | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; | Zwaag, 2009 |
| AutCNV0000379 | 19 | 19q13.2 | - | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; | Zwaag, 2009 |
| AutCNV0000380 | 19 | 19q13.42 | - | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; | Zwaag, 2009 |
| AutCNV0000381 | 19 | 19q13.42 | - | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; | Zwaag, 2009 |
| AutCNV0000382 | 22 | 22q12.3 | - | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; | Zwaag, 2009 |
| AutCNV0000383 | 22 | 22q13.2 | - | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; | Zwaag, 2009 |
| AutCNV0000384 | 22 | 22q13.2 | - | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; | Zwaag, 2009 |
| AutCNV0000385 | 22 | 22q13.33 | - | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; | Zwaag, 2009 |
| AutCNV0000386 | 22 | 22q13.33 | - | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; | Zwaag, 2009 |
| AutCNV0000388 | 8 | 8p23.1 | loss | 12 | 8 | Overlapping/Recurrent CNVs; Significant Enriched CNVs; | Cho, 2009 |
| AutCNV0000389 | 17 | 17p11.2 | loss | 4 | 0 | Overlapping/Recurrent CNVs; Significant Enriched CNVs; | Cho, 2009 |
| AutCNV0004962 | 22 | 22q11.22 | loss | 130 | 0 | CNVs Only Present In Patients; Significant Enriched CNVs; | Hadley D, 2014 |
| AutCNV0004963 | 5 | 5q11.1 | loss | 70 | 8 | CNVs Only Present In Patients; Significant Enriched CNVs; | Hadley D, 2014 |
| AutCNV0004964 | 15 | 15q12 | gain | 28 | 0 | CNVs Only Present In Patients; Significant Enriched CNVs; | Hadley D, 2014 |
| AutCNV0004965 | 15 | 15q12 | gain | 27 | 1 | CNVs Only Present In Patients; Significant Enriched CNVs; | Hadley D, 2014 |
| AutCNV0004966 | 15 | 15q13.1 | gain | 24 | 0 | CNVs Only Present In Patients; Significant Enriched CNVs; | Hadley D, 2014 |
| AutCNV0004973 | 1 | 1q21.1 | - | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; de novo CNVs; | Sanders SJ, 2015 |
| AutCNV0004976 | 7 | 7q11.23 | - | - | - | CNVs Only Present In Patients; Significant Enriched CNVs; de novo CNVs; | Sanders SJ, 2015 |